Elevance Health Inc. Stock News

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive

The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.

Hospital revenue has grown by nearly 8% year-to-date in 2024. While hospital and medical costs are aiming to moderate, what does this entail for healthcare stocks and the sector at large?

A new list of 27 new dividend increases, including King Kimberly-Clark and three other champions.

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Elevance Health (ELV) closed at $512.17 in the latest trading session, marking a +0.55% move from the prior day.

Today, we are looking at some dividend contenders and then applying further criteria based on growth, payout ratio and valuation to find 25 names worth exploring further. We then give three companies

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the b

Here is how Elevance Health (ELV) and HCA Healthcare (HCA) have performed compared to their sector so far this year.

In this series, I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by qua

The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those l

Here is how Elevance Health (ELV) and McKesson (MCK) have performed compared to their sector so far this year.

Elevance Health reported Q4 earnings that beat expectations for both EPS and revenue. The company exceeded its 2023 guidance but disappointed with its 2024 guidance, predicting flat to low single-digi

Elevance Health rewarded shareholders with a 10.1% hike in its quarterly dividend per share. The managed care company's operating revenue and adjusted diluted EPS climbed in the fourth quarter. Elevan